.甘糖酯对充血性心力衰竭患者血清肿瘤坏死因子-α浓度的影响及其意义[J].中国海洋药物,2000,19(2):37-38.
甘糖酯对充血性心力衰竭患者血清肿瘤坏死因子-α浓度的影响及其意义
THE INFLUENCE AND ITS SIGNIFICANCE OF PGMS TO SERUM TUMOR NECROSIS FACTOR-α IN PATIENTS WITH CONGESTIVE HEART FAILURE
  
DOI:
中文关键词:  甘糖酯,充血性心力衰竭,肿瘤坏死因子-α
English Keywords:PGMS,Tumor necrosis factor,Congestive heart failure
Fund Project:
摘要点击次数: 2487
全文下载次数: 23
中文摘要:
      目的:为探讨甘糖酯(PGMS)在治疗慢性充血心力衰竭(CHF)中的作用。方法:将40例CHF患者随机分为两组。PGMS组(20例)在常规治疗心衰的基础上加用PGMS100mg,tid,2w后与常规心衰组(20例)进行比较。结果:在PGMS组,CHF患者血清肿瘤坏死因子-α(TNF-α)浓度降低较常规组显著(P<0.05),且左室射血分数明显改善(P<0.05)。提示:PGMS在治疗CHF过程中,可通过对机体内TNF-α浓度的调节,发挥其降低血液黏度、保护血管内皮细胞功能和抑制脂质过氧化物生成的作用。
English Summary:
      ObjectiveIn order to investment the value of Proplylene glucol mannurate sulfate (PGMS) in the treatment of congestive heart failure (CHF).Methods40 patients with CHF were divided into 2 groups randomly.In addition to normal treatment,100mg PGMS was given to PGMS group,tid.After two weeks treatment,PGMS group was compared with controlled.ResultsIn PGMS group,the serum level of tumor necrosis factor-α(TNF-α)reduced greatly(P0.05)and the left ventricular eject fraction (LVEF)improved greatly (P0.05)than that of controlled group.ConclusionDuring the treatment of CHF,PGMS can reduce blood viscosity,protects the integral of blood vessel endodermis and resists the LPO.
查看全文  查看/发表评论  下载PDF阅读器
关闭